After the implementation of the Drug Administration Law of the People's Republic of China, in the light of Article 310 of the Good Manufacturing Practice for Drugs (2010 Revision), NMPA has revised the Blood Products Appendix. The Appendix was issued as a supporting document for the Good Manufacturing Practice for Drugs (2010 Revision) on July 2, 2020, and shall come into force as of October 1, 2020.